Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy-Reference-Cited by-同舟云学术

Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy

Published:2018-09-28 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Ahmed Mohamed I. M.,Ntinginya Nyanda E.,Kibiki Gibson,Mtafya Bariki A,Semvua Hadija,Mpagama Stellah,Mtabho Charles,Saathoff Elmar,Held Kathrin,Loose Rebecca,Kroidl Inge,Chachage Mkunde,Both Ulrich von,Haule Antelmo,Mekota Anna-Maria,Boeree Martin J.,Gillespie Stephen H.,Hoelscher Michael,Heinrich Norbert,Geldmacher Christof

Funder

European and Developing Countries Clinical Trials Partnership

Bundesministerium für Bildung und Forschung

European Commission

Deutsches Zentrum für Infektionsforschung

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. End TB Strategy: Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015

2. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo;Schuetz;PLoS ONE,2011